MedTrace Logo

Oxygen Requirements and Use in Patients With COVID-19 in LMICs

NCT04918875 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2023-08-23

No results posted yet for this study

Summary

This observational cohort study will enroll patients in LMICs with suspected or confirmed COVID-19 on oxygen or deemed to require oxygen therapy based on objective criteria. Demographics and risk factor information will be collected from participants. Participants will be followed for 7 days or until outcome (hospital discharge or death). Facility level metrics on oxygen availability will also be collected at the beginning of site enrolment.

Conditions

Sponsors & Collaborators

  • Pryanka Relan

    lead OTHER

Principal Investigators

  • WHO · World Health Organization

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-04-30
Completion
2023-10-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04918875 on ClinicalTrials.gov